Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44)
| Jurisdiction: |
Federal
|
| Incentive Type: | Grant Program |
| Industries: |
Health And Safety, Technology
|
| Eligible Sector: | Business |
| Category: |
Financial Incentive
|
| Time Period: |
FY 2015
|
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
The Radiological/Nuclear Medical Countermeasure Product Development Program was designed to fund specific product development activities for radiological/nuclear medical countermeasures leading to Investigational New Drug or Device Exemption submission packages. This program supports non-clinical and preclinical development activities that include but are not excluded to:
- Radiation injury post-exposure treatment products
- Medical products for the lungs that remove or
- Biodosimetry devices that are able to rapidly and accurately identify individuals who are in need of treatment
- New medical formulas that administration can be expedited in emergency situations
Funds typically do not exceed $300,000 for Phase I projects and $1,000,000 for Phase II projects. Applicants are encourage to contact the NIH program officials before proposing anything in excess of the guidelines.
Applications must be complete and received before the deadline.
